From EUROCHIP-1 to EUROCHIP-2

EUROCHIP-1&2
Health Indicators
for Monitoring Cancer
in Europe
Health Monitoring Program (HMP)
EUROPEAN COMMISSION: HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL
Presentè par A Micheli, L Cherie Challine, P Baili,J Bloch, P Grosclaude,
C Amati, M Velten, F Berrino, C Martinez, M Coleman
Www.istitutotumori.mi.it/project/eurochip/homepage.htm

Europe is characterised by unacceptable
inequalities - inègalitèes - in cancer control
AN -travaille - INTECTUAL WORK INVOLVING CANCER EXPERTS OF EU
MEMBERS, CANCER NETWORKS, INSTITUTES AND ORGANISATIONS
To produce a list of health indicators which
describe cancer in Europe finalized - finalisation- :
a) to help the development of the European
Health Information System - banque d’information
Européenne de la santè
c) to promote action in the fight against - contre -
cancer
EUROCHIP-1 AIMS

Life expectancy
trends in Europe
Source: Population
Division of the
Department of Economic
and Social Affairs of the
United Nations
Secretariat (2003). World
Population Prospects:
The 2002 Revision

World-age-stand. incidence
$PPP rate per 100,000
I) GDP<15611 216
II) 15611<GDP<17538 244
III) GDP>17538 253
GDP and cancer incidence
I, Estonia, Poland, Slovenia, Slovakia, and Spain;
II, UK, Finland, Netherland, Sweden, Italy, and Austria;
III, Iceland, Denmark, France, Germany, and Switzerland

5-year cancer relative survival
$PPP %
I) GDP<15611 31
II) 15611<GDP<17538 43
III) GDP>17538 45
GDP and cancer survival
I, Estonia, Poland, Slovenia, Slovakia, and Spain;
II, UK, Finland, Netherland, Sweden, Italy, and Austria;
III, Iceland, Denmark, France, Germany, and Switzerland